- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Beall, E. L.
- Articles by Rio, D. C.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Beall, E. L.
- Articles by Rio, D. C.
Identification and Analysis of a Hyperactive Mutant Form of Drosophila P-Element Transposase
Eileen L. Bealla, Matthew B. Mahoneya, and Donald C. Rioaa Department of Molecular and Cell Biology, University of California, Berkeley, California 94720-3204
Corresponding author: Donald C. Rio, University of California, Berkeley, CA 94720-3204., don_rio{at}uclink4.berkeley.edu (E-mail)
Communicating editor: A. J. LOPEZ
| ABSTRACT |
|---|
Transposition in many organisms is regulated to control the frequency of DNA damage caused by the DNA breakage and joining reactions. However, genetic studies in prokaryotic systems have led to the isolation of mutant transposase proteins with higher or novel activities compared to those of the wild-type protein. In the course of our study of the effects of mutating potential ATM-family DNA damage checkpoint protein kinase sites in the Drosophila P-element transposase protein, we found one mutation, S129A, that resulted in an elevated level of transposase activity using in vivo recombination assays, including P-element-mediated germline transformation. In vitro assays for P-element transposase activity indicate that the S129A mutant exhibits elevated donor DNA cleavage activity when compared to the wild-type protein, whereas the strand-transfer activity is similar to that of wild type. This difference may reflect the nature of the in vitro assays and that normally in vivo the two reactions may proceed in concert. The P-element transposase protein contains 10 potential consensus phosphorylation sites for the ATM family of PI3-related protein kinases. Of these 10 sites, 8 affect transposase activity either positively or negatively when substituted individually with alanine and tested in vivo. A mutant transposase protein that contains all eight N-terminal serine and threonine residues substituted with alanine is inactive and can be restored to full activity by substitution of wild-type amino acids back at only 3 of the 8 positions. These data suggest that the activity of P-element transposase may be regulated by phosphorylation and demonstrate that one mutation, S129A, results in hyperactive transposition.
THE mobility of transposable elements is controlled to minimize the level of DNA damage that may result in lethality of the host cell. Thus, many transposons have evolved elaborate regulatory strategies to modulate the level of their movement. In many cases, the "wild-type" transposase protein works inefficiently and with a low turnover number as an enzyme, yet like other enzymes, works with exquisite specificity (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Control of the cell cycle, as well as the response of cells to DNA damage, involves cascades of protein phosphorylation (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
The ATM family of protein kinases appears to have evolved from lipid kinases and functions physiologically to regulate cell cycle progression and DNA damage responses (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
The Drosophila P-transposable element is 2.9 kb in length and encodes an 87-kD transposase protein that mediates the cleavage and strand-transfer steps of the transposition reaction (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
|
Here we report that the P-element transposase protein contains 10 potential phosphorylation sites for ATM-family kinases. When the serine or threonine residues in these sites are changed to alanine, transposase activity is affected either positively or negatively using an in vivo recombination assay. Seven of the 8 sites at the N terminus of the protein show a reduced activity when individually substituted with alanine, while 1 site, serine 129 (S129), shows an elevated activity. None of the mutations affect the stability or site-specific DNA-binding activity of the transposase protein. The S129A mutant also showed elevated activity in embryo microinjection assays for P-element-mediated germline transformation. Finally, the S129A mutant exhibited activity in vitro higher than that of wild type in an assay for donor DNA cleavage but not in an assay for strand-transfer integration. These data identify a mutant P-element transposase with an elevated activity and suggest that phosphorylation by an ATM-family protein kinase might regulate activity of the P-element transposase protein in vivo.
| MATERIALS AND METHODS |
|---|
Recombinant DNA and in vitro mutagenesis:
The wild-type transposase-encoding plasmid pBSKS(+)PAcNNTnpII (![]()
![]()
![]()
The plasmids encoding the two alanine substitutions in the C terminally located potential ATM-family protein kinase phosphorylation sites (T405 and S459) were generated as follows: Single-stranded DNA was produced from pBSKS(+)PAcNNTnpII as described above. Mutations were introduced by annealing oligonucleotides containing the desired nucleotide changes to the single-stranded DNA. Incorporation of the desired mutation was confirmed by DNA sequence analysis using Sequenase 2.0 as described by the manufacturer (United States Biochemical, Cleveland) and the primer 5'-CACATTAATGTTCGATCGC. Each mutant was cleaved with SacI and EcoRI to produce a 0.5-kb fragment. pBSKS(+)PAcNNTnpII was cleaved with EcoRI and XbaI to produce a 0.9-kb fragment and SacI and ScaI to produce a 0.95-kb fragment. Mutant and wild-type DNA fragments were inserted into the pBSKS(+)PAcNNTnpII vector cleaved with ScaI and XbaI (a 5.6-kb fragment generated by partial cleavage with ScaI) to generate the mutated transposase-encoding plasmids.
The plasmid encoding the transposase protein with alanine substitutions at all eight N terminally located potential ATM-family member phosphorylation sites (-All) was generated as follows: pBSKS(+)PAcNNTnpII containing alanine substitutions at all sites except S32 was used to generate the all-sites mutated plasmid by double-stranded DNA mutagenesis as described (![]()
Tissue culture transfection assay:
The reporter plasmid pISP-2/Km (10 µg) and wild-type or mutant transposase-encoding plasmids [pBSKS(+) PAcTnp (10 µg)] were transfected into the Drosophila Schneider L2 cell line by standard calcium-phosphate methods (![]()
![]()
![]()
![]()
![]()
![]()
Embyro microinjection and transformation assay:
Germline transformation of Drosophila strain w1118 was carried out using standard microinjection methods with bleach dechorionation (![]()
Generation of Drosophila tissue culture cells expressing the S129A transposase:
A stable Drosophila Schneider L2 cell line using plasmid pUChygMT-NNTnpII-S129A (in which the S129A mutation was transferred into pUChygMT-NNTnpII) was generated by transfection with calcium phosphate coprecipitation for 24 hr followed by selection with 200 µg/ml hygromycinB (![]()
Transposase protein purification:
Wild-type and S129A P-element transposase proteins were partially purified from the Drosophila Schneider L2 stable cell lines following CuSO4 induction as described (![]()
![]()
In vitro cleavage and strand-transfer assays:
Assays for P-element donor DNA cleavage and strand transfer were carried out exactly as described previously with the same DNA substrates (![]()
![]()
![]()
|
|
|
|
| RESULTS |
|---|
Putative ATM-family phosphorylation site mutations affect transposase activity in vivo:
To examine a possible role for ATM-family kinase phosphorylation in P-element transposition, we expressed mutant transposase proteins that contain individual alanine substitutions at each potential ATM-family protein kinase site in Drosophila tissue culture cells. These experiments were prompted by the finding that P-element transposase is a phosphoprotein (as assessed by in vivo labeling with 32P and phosphoamino acid analysis; E. L. BEALL and D. C. RIO, unpublished results) and the presence in the transposase sequence of 10 putative ATM-family kinase recognition sites (Fig 1). The mutant transposase proteins were tested for activity using a plasmid-based P-element excision assay (![]()
![]()
7% activity), followed by threonine 143 (Fig 2A, T143A at
24% activity) and serine 51 (Fig 2A, S51A at
41% activity). Interestingly, the transposase mutant containing an alanine substitution at serine 129 showed increased activity (Fig 2A, S129A at
172% activity), suggesting that phosphorylation at this site might be inhibitory. Additionally, this S129A mutant shows elevated levels of activity in embryo P-element injection/transformation experiments (see below; Table 1). These data suggest that phosphorylation at S51, T96, and T143 may be essential for a high level of transposase activity. One mutation, S129A, exhibits an elevated transposase activity in vivo, suggesting that a phosphorylation event at this site might be inhibitory.
|
Occasionally, serine or threonine phosphorylation can be mimicked by aspartate (D) or glutamate (E) substitution at the phosphorylated amino acid position (![]()
Substitution of D at S51 partially restored transposase activity (Fig 3, compare S51A at
39% activity to S51D at
76% activity), whereas substitution of E at either T96 or T143 caused even more reduction in transposase activity (Fig 3, compare T96A at
10% activity to T96E at
6% activity and T143A at
25% activity to T143E at
2% activity). Substitution of either D or S at position T96 showed a modest increase in transposase activity (Fig 3, compare T96A at
10% activity to T96D at
12% activity and T96S at
12% activity). The acidic amino acid substitutions did not affect the expression levels of the mutant transposase proteins (data not shown). Among the cases examined, it appeared that there was, at most, a twofold increase in transposase activity when an acidic amino acid was substituted for a potential phosphorylation site. It is worth noting that substitution of serine at T96 did not restore transposase activity, suggesting that a threonine at position 96, possibly due to the different sizes of the side chains, is critical for transposase activity.
Finally, if phosphorylation at residue S129 inhibits transposase activity, then substitution of D at this position should result in reduced transposase activity. As shown in Fig 3, substitution of D at position S129 resulted in a nearly threefold reduction in transposase activity (compare S129A at
172% activity with S129D at
54% activity). These observations suggest that possible phosphorylation at S129 is inhibitory in vivo.
To further examine the critical nature of S51, T96, and T143 for transposase activity, we tried to reactivate the transposase protein containing alanine substitutions at all of the eight potential ATM-family phosphorylation sites by replacing the alanine residues with the corresponding wild-type amino acid. Substitution of T96 back into the -All alanine mutant protein resulted in a nearly 24-fold increase in transposase activity (Fig 4, compare -All at
0.5% activity to T96WT at
12% activity). Even though substitution of T143 back into the -All protein resulted in only a 7-fold increase in transposase activity (Fig 4, T143WT at
4% activity), substitution of both T96 and T143 back into the -All protein resulted in nearly a 70-fold increase in transposase activity (Fig 4, T96/T143WT at
33% activity). Most strikingly, replacement of S51, T96, and T143 into the -All protein resulted in a nearly complete restoration of transposase activity (Fig 4, S51/T96/T143WT at
85% activity). Note that all of these mutants contain alanine at the inhibitory site, S129. Because a stimulation in transposase activity above wild type was not observed with the S51/T96/T143WT mutant protein (containing S129A), additional potential ATM-family phosphorylation sites must contribute to maximal transposase activity. Together, these data suggest that modification at several potential ATM-family kinase sites may regulate transposase activity both positively and negatively in vivo.
The S129A mutant transposase showed an elevated frequency of P-element-mediated germline transformation:
The finding that the S129A mutant transposase protein exhibited an elevated level of activity in the tissue culture cell recombination assay prompted us to ask if this modified protein would also increase the efficiency of P-element-mediated germline transformation. Following coinjection of w1118 preblastoderm embryos with plasmid containing either wild type or S129A transposase expressed from the strong actin 5C promoter, along with the standard P-element transformation vector pw8, normal matings were performed to identify germline transformants. As shown in Table 1, in two independent experiments using either 50 or 250 µg/ml of the indicated actin-transposase helper DNA, the S129A transposase yielded a three- to fivefold increase in the frequency of recovering w+ transformants. Moreover, when these transgenic strains were assayed for the number of independent insertions using DNA blot hybridization, there was a general trend of a larger number of independent transformants being obtained with the S129A transposase helper (Table 1, last two columns). Indeed, in some cases using the higher (250 µg/ml) concentration of the S129A helper plasmid, multiple insertions were obtained in the same initial transformant, suggesting that multiple insertional events occurred in the same gamete. Thus, taken together, these data indicate that the S129A transposase can yield higher frequencies of germline P-element transformation when compared to the wild-type enzyme. This mutant form of P-element transposase may be generally useful to improve the efficiency of P-element-mediated germline transformation.
The S129A transposase exhibited elevated donor DNA cleavage but not elevated strand-transfer activities in vitro:
Because we observed elevated activity with the S129A mutant in two different in vivo assays for transposase activity (see above) and because we had previously developed in vitro assays for both the donor DNA cleavage and strand-transfer activities of P-element transposase (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
The assay for donor DNA cleavage by transposase uses a plasmid carrying a 0.6-kb P element, which, when released from the plasmid backbone, can be detected by DNA blot hybridization of the reaction products. As is apparent in Fig 5B, at equivalent concentrations of transposase the S129A mutant exhibits a significant increase (three- to fivefold) in donor DNA cleavage activity compared to wild type. At the lowest concentration of protein tested, no activity was observed for the wild-type transposase, whereas low activity was observed for S129A (Fig 5B; compare lanes 9 with lane 3). At higher protein concentrations, S129A activity was higher than that of wild type (Fig 5B; compare lanes 11 and 13 with lanes 5 and 7). All reactions required GTP as a cofactor to observe P-element excision. Thus, taken together, these results show that, at equivalent transposase concentrations, the S129A mutant shows an elevated activity for donor DNA cleavage compared to the wild-type protein.
The assay for strand transfer by transposase uses radiolabeled oligonucleotide substrates carrying the 3' P-element end, including a transposase binding site, and an unlabeled plasmid DNA as an integration target (![]()
| DISCUSSION |
|---|
Mutation of potential ATM-family phosphorylation sites modulates P-element transposase activity:
Here we report that multiple potential ATM-family phosphorylation sites are in the P-element transposase protein (Fig 1) and that mutation of eight of these sites modulates P-element transposase activity using an in vivo recombination assay. Alanine substitution at several of the potential ATM-family phosphorylation sites (most notably, S51, T96, and T143) resulted in a severe reduction in transposase activity, whereas alanine substitution at one site (S129) resulted in increased transposase activity, suggesting that phosphorylation at these sites might regulate transposase activity both positively and negatively. Using ligation-mediated PCR, we found that alanine substitution at S51, T96, or T143 inhibits transposase at or prior to the donor DNA cleavage step of the transposition reaction (E. L. BEALL and D. C. RIO, data not shown). The exact sites of transposase protein phosphorylation in vivo have yet to be determined. However, it should be noted that any particular site of phosphorylation in vivo may be difficult or impossible to detect if, for instance, the stoichiometry of phosphorylation is low, if phosphorylation is regulated during the cell cycle, or if phosphorylation has a rapid turnover of the phosphate at a given position.
A hyperactive mutant of P-element transposase:
It is interesting to note that one mutant, S129A, shows increased activity in both the tissue culture transfection assay and by direct embryo microinjection for P-element-mediated germline transformation. The S129A mutant displayed elevated in vitro donor DNA cleavage, but not strand-transfer activity. This finding is not surprising since we know little about the complex nature of the steps involved in the assembly and activation of the donor cleavage synaptic complex, whereas the strand-transfer reaction using oligonucleotide substrates exhibits relaxed DNA substrate requirements. It is easily conceivable that the S129A mutation could somehow promote synaptic complex assembly and increase donor DNA cleavage without affecting the strand-transfer reaction.
The S129 site was initially recognized as a potential site for the ATM family of nuclear protein kinases (Fig 1). If S129 is phosphorylated in vivo, it is possible that phosphorylation at this site negatively regulates transposase activity by preventing assembly of a functional transposition complex at the transposon termini and/or by controlling the catalytic rate of the enzyme, so that transposition occurs only at a specific point in the cell cycle. The increased activity displayed by the S129A protein may be due simply to an uncoupling of the transposase activity from the normal controls that might operate during DNA damage checkpoints and the cell cycle (![]()
![]()
A potential role for regulation of transposase activity throughout the cell cycle or in response to external stimuli:
Because repair of the gap following P-element excision in vivo is greatly facilitated by homologous sequences, it is thought that transposase activity is modulated throughout the cell cycle such that the transposase protein is active only in the S or G2 phases (![]()
![]()
![]()
![]()
![]()
![]()
![]()
Previous phosphoamino acid analysis of in vivo radiolabeled transposase protein revealed that transposase is phosphorylated on serine, threonine, and tyrosine (E. L. BEALL and D. C. RIO, unpublished results). A regulatory role for tyrosine phosphorylation is known for a number of proteins in vivo (![]()
![]()
![]()
![]()
![]()
![]()
Several studies have suggested that external or environmental stimuli may trigger DNA rearrangements (![]()
![]()
![]()
![]()
![]()
![]()
![]()
| ACKNOWLEDGMENTS |
|---|
We thank Mike Botchan, Kathy Collins, and Siobhan Roche for helpful suggestions and critical reading of the manuscript. We thank Y. Mul and B. Wang for making some initial observations regarding a small subset of the mutations analyzed here. This work was supported by a grant from the National Institutes of Health (R01GM48862).
Manuscript received February 5, 2002; Accepted for publication June 13, 2002.
| LITERATURE CITED |
|---|
ADAMS, M. D., S. E. CELNIKER, R. A. HOLT, C. A. EVANS, and J. D. GOCAYNE et al., 2000 The genome sequence of Drosophila melanogaster. Science 287:2185-2195.
AUSUBEL, F. M., R. BRENT, R. E. KINGSTON, D. D. MOORE, J. G. SEIDMAN et al., 1987 Current Protocols in Molecular Biology. John Wiley & Sons, New York.
BANGA, S. S., A. VELAZQUEZ, and J. B. BOYD, 1991 P transposition in Drosophila provides a new tool for analyzing postreplication repair and double-strand break repair. Mutat. Res. 255:79-88.[Medline]
BANIN, S., L. MOYAL, S. SHIEH, Y. TAYA, and C. W. ANDERSON et al., 1998 Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677.
BEALL, E. L. and D. C. RIO, 1996 Drosophila IRBP/Ku p70 corresponds to the mutagen-sensitive mus309 gene and is involved in P-element excision in vivo. Genes Dev. 10:921-933.
BEALL, E. L. and D. C. RIO, 1997 Drosophila P element transposase is a novel site-specific endonuclease. Genes Dev. 11:2137-2151.
BEALL, E. L. and D. C. RIO, 1998 Transposase makes critical contacts with, and is stimulated by, single-stranded DNA at the P element termini in vitro. EMBO J. 17:2122-2136.[Medline]
BLUNT, T., N. J. FINNIE, G. E. TACCIOLI, G. C. SMITH, and J. DEMENGEOT et al., 1995 Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80:813-823.[Medline]
CANMAN, C. E., D. S. LIM, K. A. CIMPRICH, Y. TAYA, and K. TAMAI et al., 1998 Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-1679.
CHEN, J. and F. W. ALT, 1993 Gene rearrangement and B-cell development. Curr. Opin. Immunol. 5:194-200.[Medline]
CRAIG, N. L., 1997 Target site selection in transposition. Annu. Rev. Biochem. 66:437-474.[Medline]
CRITCHLOW, S. E. and S. P. JACKSON, 1998 DNA end-joining: from yeast to man. Trends Biochem. Sci. 23:394-398.[Medline]
CURCIO, M. J. and D. J. GARFINKEL, 1999 New lines of host defense: inhibition of Ty1 retrotransposition by Fus3p and NER/TFIIH. Trends Genet. 15:43-45.[Medline]
DUROCHER, D. and S. P. JACKSON, 2001 DNA-PK, ATM and ATR as sensors of DNA damage: Variations on a theme? Curr. Opin. Cell Biol. 13:225-231.[Medline]
EGGLESTON, W. B., D. M. JOHNSON-SCHLITZ, and W. R. ENGELS, 1988 P-M hybrid dysgenesis does not mobilize other transposable element families in D. melanogaster. Nature 331:368-370.[Medline]
ELLEDGE, S. J., 1996 Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672.
ENGELS, W. R., D. M. JOHNSON-SCHLITZ, W. B. EGGLESTON, and J. SVED, 1990 High-frequency P element loss in Drosophila is homolog dependent. Cell 62:515-525.[Medline]
FELLER, S. M., R. REN, H. HANAFUSA, and D. BALTIMORE, 1994 SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. Trends Biochem. Sci. 19:453-458.[Medline]
FUGMANN, S. D., I. J. VILLEY, L. M. PTASZEK, and D. G. SCHATZ, 2000 Identification of two catalytic residues in RAG1 that define a single active site within the RAG1/RAG2 protein complex. Mol. Cell 5:97-107.[Medline]
GERASIMOVA, T. I., L. J. MIZROKHI, and G. P. GEORGIEV, 1984 Transposition bursts in genetically unstable Drosophila melanogaster. Nature 309:714-716.
GIACCIA, A. J. and M. B. KASTAN, 1998 The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:2973-2983.
GLOOR, G. B., J. MORETTI, J. MOUYAL, and K. J. KEELER, 2000 Distinct P-element excision products in somatic and germline cells of Drosophila melanogaster.. Genetics 155:1821-1830.
HUNTER, T., 1995 When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83:1-4.[Medline]
JEGGO, P. A., A. M. CARR, and A. R. LEHMANN, 1998 Splitting the ATM: distinct repair and checkpoint defects in ataxia-telangiectasia. Trends Genet. 14:312-316.[Medline]
JIMENEZ, G. S., F. BRYNTESSON, M. I. TORRES-ARZAYUS, A. PRIESTLEY, and M. BEECHE et al., 1999 DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 400:81-83.[Medline]
JIN, S., S. INOUE, and D. T. WEAVER, 1997 Functions of the DNA-dependent protein kinase. Cancer Surv. 29:221-261.[Medline]
JOHNSON, L. N. and M. O. O'REILLY, 1996 Control by phosphorylation. Curr. Opin. Struct. Biol. 6:762-769.[Medline]
KAUFMAN, P. D. and D. C. RIO, 1992 P element transposition in vitro proceeds by a cut-and-paste mechanism and uses GTP as a cofactor. Cell 69:27-39.[Medline]
KENNEDY, A. K. and D. B. HANIFORD, 1996 Isolation and characterization of IS10 transposase separation of function mutants: identification of amino acid residues in transposase that are important for active site function and the stability of transposition intermediates. J. Mol. Biol. 256:533-547.[Medline]
KHANNA, K. K. and S. P. JACKSON, 2001 DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27:247-254.[Medline]
KHARBANDA, S., R. REN, P. PANDEY, T. D. SHAFMAN, and S. M. FELLER et al., 1995 Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376:785-788.[Medline]
KHARBANDA, S., P. PANDEY, S. JIN, S. INOUE, and A. BHARTI et al., 1997 Functional interaction between DNA-PK and c-Abl in response to DNA damage. Nature 386:732-735.[Medline]
KIM, D. R., Y. DAI, C. L. MUNDY, W. YANG, and M. A. OETTINGER, 1999 Mutations of acidic residues in RAG1 define the active site of the V(D)J recombinase. Genes Dev. 13:3070-3080.
KIM, S. T., D. S. LIM, C. E. CANMAN, and M. B. KASTAN, 1999 Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274:37538-37543.
KO, L. J. and C. PRIVES, 1996 p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
KUSANO, K., D. M. JOHNSON-SCHLITZ, and W. R. ENGELS, 2001 Sterility of Drosophila with mutations in the Bloom syndrome genecomplementation by Ku70. Science 291:2600-2602.
LAMPE, D. J., B. J. AKERLEY, E. J. RUBIN, J. J. MEKALANOS, and H. M. ROBERTSON, 1999 Hyperactive transposase mutants of the Himar1 mariner transposon. Proc. Natl. Acad. Sci. USA 96:11428-11433.
LANDREE, M. A., J. A. WIBBENMEYER, and D. B. ROTH, 1999 Mutational analysis of RAG1 and RAG2 identifies three catalytic amino acids in RAG1 critical for both cleavage steps of V(D)J recombination. Genes Dev. 13:3059-3069.
LEE, C. C., Y. M. MUL, and D. C. RIO, 1996 The Drosophila P-element KP repressor protein dimerizes and interacts with multiple sites on P-element DNA. Mol. Cell. Biol. 16:5616-5622.[Abstract]
LEE, C. C., E. L. BEALL, and D. C. RIO, 1998 DNA binding by the KP repressor protein inhibits P element transposase activity in vitro.. EMBO J. 17:4166-4174.[Medline]
LEE, J. and S. DESIDERIO, 1999 Cyclin A/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair. Immunity 11:771-781.[Medline]
LEES-MILLER, S. P., K. SAKAGUCHI, S. J. ULLRICH, E. APPELLA, and C. W. ANDERSON, 1992 Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12:5041-5049.
LIEBER, M. R., U. GRAWUNDER, X. WU, and M. YANEVA, 1997 Tying loose ends: roles of Ku and DNA-dependent protein kinase in the repair of double-strand breaks. Curr. Opin. Genet. Dev. 7:99-104.[Medline]
MCCLINTOCK, B., 1984 The significance of responses of the genome to challenge. Science 226:792-801.
MIZUUCHI, K., 1997 Polynucleotidyl transfer reactions in site-specific DNA recombination. Genes Cells 2:1-12.[Abstract]
MUL, Y. M. and D. C. RIO, 1997 Reprogramming the purine nucleotide cofactor requirement of Drosophila P element transposase in vivo. EMBO J. 16:4441-4447.[Medline]
NORBURY, C. and P. NURSE, 1992 Animal cell cycles and their control. Annu. Rev. Biochem. 61:441-470.[Medline]
O'BROCHTA, D. A. and A. M. HANDLER, 1988 Mobility of P elements in drosophilids and nondrosophilids. Proc. Natl. Acad. Sci. USA 85:6052-6056.
PANDITA, T. K., H. B. LIEBERMAN, D. S. LIM, S. DHAR, and W. ZHENG et al., 2000 Ionizing radiation activates the ATM kinase throughout the cell cycle. Oncogene 19:1386-1391.[Medline]
QIU, J. X., S. B. KALE, H. YARNELL SCHULTZ, and D. B. ROTH, 2001 Separation-of-function mutants reveal critical roles for RAG2 in both the cleavage and joining steps of V(D)J recombination. Mol. Cell 7:77-87.[Medline]
REZNIKOFF, W. S., A. BHASIN, D. R. DAVIES, I. Y. GORYSHIN, and L. A. MAHNKE et al., 1999 Tn5: a molecular window on transposition. Biochem. Biophys. Res. Commun. 266:729-734.[Medline]
RIO, D. C., F. A. LASKI, and G. M. RUBIN, 1986 Identification and immunochemical analysis of biologically active Drosophila P element transposase. Cell 44:21-32.[Medline]
SAKAI, J. and N. KLECKNER, 1996 Two classes of Tn10 transposase mutants that suppress mutations in the Tn10 terminal inverted repeat. Genetics 144:861-870.[Abstract]
SEKELSKY, J. J., K. C. BURTIS, and R. S. HAWLEY, 1998 Damage control: the pleiotropy of DNA repair genes in Drosophila melanogaster. Genetics 148:1587-1598.
SEKELSKY, J. J., M. H. BRODSKY, and K. C. BURTIS, 2000 DNA repair in Drosophila: insights from the Drosophila genome sequence. J. Cell Biol. 150:F31-36.
SHIEH, S. Y., M. IKEDA, Y. TAYA, and C. PRIVES, 1997 DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334.[Medline]
SMITH, G. C. and S. P. JACKSON, 1999 The DNA-dependent protein kinase. Genes Dev. 13:916-934.
SONGYANG, Z., G. GISH, G. MBAMALU, T. PAWSON, and L. C. CANTLEY, 1995 A single point mutation switches the specificity of group III Src homology (SH) 2 domains to that of group I SH2 domains. J. Biol. Chem. 270:26029-26032.
SPRADLING, A. C., 1986 P element-mediated transformation, pp. 175197 in Drosophila: A Practical Approach, edited by D. ROBERTS. IRL Press, Oxford.
STAVELEY, B. E., T. R. HESLIP, R. B. HODGETTS, and J. B. BELL, 1995 Protected P-element terminii suggest a role for the inverted-repeat-binding protein in transposase-induced gap repair in Drosophila melanogaster.. Genetics 139:1321-1329.[Abstract]
STELLWAGEN, A. E. and N. L. CRAIG, 1997 Gain-of-function mutations in TnsC, an ATP-dependent transposition protein that activates the bacterial transposon Tn7. Genetics 145:573-585.[Abstract]
TIBBETTS, R. S., K. M. BRUMBAUGH, J. M. WILLIAMS, J. N. SARKARIA, and W. A. CLIBY et al., 1999 A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:152-157.
WANG, J. Y., 1993 Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Biol. 3:35-43.
WOODRUFF, R. C., J. L. BLOUNT, and J. N. THOMPSON, JR., 1987 Hybrid dysgenesis in D. melanogaster is not a general release mechanism for DNA transpositions. Science 237:1206-1218.
YARNELL SCHULTZ, H., M. A. LANDREE, J. X. QIU, S. B. KALE, and D. B. ROTH, 2001 Joining-deficient RAG1 mutants block V(D)J recombination in vivo and hairpin opening in vitro. Mol. Cell 7:65-75.[Medline]
ZAKIAN, V. A., 1995 ATM-related genes: What do they tell us about functions of the human gene? Cell 82:685-687.[Medline]
ZHOU, B. B. and S. J. ELLEDGE, 2000 The DNA damage response: putting checkpoints in perspective. Nature 408:433-439.[Medline]
This article has been cited by other articles:
![]() |
K. J. T. Venken and H. J. Bellen Transgenesis upgrades for Drosophila melanogaster Development, October 15, 2007; 134(20): 3571 - 3584. [Abstract] [Full Text] [PDF] |
||||








